Eli Lilly and Company
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Eli Lilly and Company (LLY) Business News
Track Eli Lilly and Company in real time with a live news feed covering Eli Lilly and Company stock news, official press releases, company announcements, and an archive of historical Eli Lilly and Company news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
What Moved Markets This Week
Why Eli Lilly (LLY) is a Top Momentum Stock for the Long-Term
First Look: Tech-led selloff, tariff shifts, AI funding boom
Prices, pipelines and patent cliffs: Inside pharma's big reset
2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off
Vanguard's Mid Cap Growth Filter Fails to Deliver on Its Investor Promise
First Look: McDonald's beats, Hims sued, WBD deal battle
Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know.
Baron Opportunity Fund Q4 2025 Contributors And Detractors
3 Reasons to Buy Eli Lilly Stock
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Read full article
What Moved Markets This Week
Seeking AlphaListen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Read full article
Why Eli Lilly (LLY) is a Top Momentum Stock for the Long-Term
Zacks Investment ResearchThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read full article
First Look: Tech-led selloff, tariff shifts, AI funding boom
GuruFocusStock News Tech slump hits indexes: A broad risk-off move saw Apple (AAPL) and Cisco (CSCO) lead declines, while Applied Materials (AMAT) rallied on upbeat AI t
Read full article
Prices, pipelines and patent cliffs: Inside pharma's big reset
CNBCPharma earnings weren't the main focus for drugmakers this quarter. "2025 was about understanding kind of the rules of the future of the game," McKinsey Senior Partner Greg Graves told CNBC.
Read full article
2 Biotech Stocks to Buy as AI Drug Discovery Lifts Off
24/7 Wall StreetAI-assisted drug discovery isn't just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age.
Read full article
Vanguard's Mid Cap Growth Filter Fails to Deliver on Its Investor Promise
24/7 Wall StreetIf you're building a portfolio that needs exposure to mid-cap companies with growth potential, you're choosing between two paths: buying a broad mid-cap fund and accepting whatever mix of value and growth you get, or isolating the growth segment specifically.
Read full article
First Look: McDonald's beats, Hims sued, WBD deal battle
GuruFocusStock News Futures edge up as jobs data and earnings mix: U.S. stock futures inched higher after January payrolls rose 130,000 with unemployment at 4.3%, compli
Read full article
Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know.
The Motley FoolEli Lilly and Novo Nordisk dominate the weight loss drug market, one that soon may approach $100 billion. One of these players has recently gained market share.
Read full article
Baron Opportunity Fund Q4 2025 Contributors And Detractors
Seeking AlphaSpaceX is generating significant value with the rapid expansion of its Starlink broadband service. Eli Lilly shares contributed to performance as Zepbound continues to gain share for the treatment of obesity. We decided to exit the Oracle position and book a short-term tax loss, spreading the capital across several of the investments listed above.
Read full article
3 Reasons to Buy Eli Lilly Stock
The Motley FoolEli Lilly is posting strong results, and that should continue. The drugmaker is dominating in its core therapeutic area.
Read full article